Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.

Compared to ASMs alone, ASMs plus VNS is a treatment modality associated with lower annual hospital costs over time. Our study shows that VNS is a cost-beneficial treatment for a national cohort of pediatric patients with refractory epilepsy.